Medical Opinion
Physician critiques new Alzheimer's drug approval
AI에 의해 보고됨
In an opinion piece published on MedPage Today, oncologist Vinay Prasad argues that the FDA's approval of lecanemab for Alzheimer's disease is premature and overlooks significant risks. He calls for more rigorous evidence before widespread use.